Treatment adherence and patient retention in the first year of a Phase-III clinical trial for the treatment of multiple sclerosis.

@article{Mohr1999TreatmentAA,
  title={Treatment adherence and patient retention in the first year of a Phase-III clinical trial for the treatment of multiple sclerosis.},
  author={David C. Mohr and Donald E. Goodkin and L K Masuoka and Leah P. Dick and Donna M Russo and Janelle Eckhardt and Arne Boudewyn and Louis J. Bedell},
  journal={Multiple sclerosis},
  year={1999},
  volume={5 3},
  pages={192-7}
}
The purpose of this study was to examine the relationship between patient management strategies employed by study personnel, and patient retention and adherence to treatment in the first year of a Phase III clinical trial of interferon beta-1b for treatment of secondary progressive multiple sclerosis (MS). Study staff from each of 35 sites were interviewed regarding patient management practices. Sites which were rated as more empathetic, as instilling a sense of purpose in the patient, and… CONTINUE READING